Figure 3 illustrates the within‐ and between‐group comparison of BDNF serum levels in MS patients pre‐ and post‐omega‐3 fatty acids supplementation and placebo, showing no significant differences through the Mann–Whitney U test after 12 weeks. The gene discussed is BDNF; the disease is myeloid sarcoma.